In vitro expression analysis of mutations in phenylalanine hydroxylase: linking genotype to phenotype and structure to function

Human Mutation
P J WatersC R Scriver

Abstract

Mutations in the human phenylalanine hydroxylase gene (PAH) altering the expressed cDNA nucleotide sequence (GenBank U49897) can impair activity of the corresponding enzyme product (hepatic phenylalanine hydroxylase, PAH) and cause hyperphenylalaninemia (HPA), a metabolic phenotype for which the major disease form is phenylketonuria (PKU; OMIM 261600). In vitro expression analysis of inherited human mutations in eukaryotic, prokaryotic, and cell-free systems is informative about the mechanisms of mutation effects on enzymatic activity and their predicted effect on the metabolic phenotype. Corresponding analysis of site-directed mutations in rat Pah cDNA has assigned critical functional roles to individual amino acid residues within the best understood species of phenylalanine hydroxylase. Data on in vitro expression of 35 inherited human mutations and 22 created rat mutations are reviewed here. The core data are accessible at the PAH Mutation Analysis Consortium Web site (http://www.mcgill.ca/pahdb).

References

Jan 1, 1991·Genomics·Y OkanoS L Woo
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·T WangT Oura
May 2, 1991·The New England Journal of Medicine·Y OkanoH Lou
Apr 5, 1991·Journal of Molecular Biology·R CelikelN H Xuong
Mar 1, 1991·European Journal of Pediatrics·Y OkanoS L Woo
Jan 1, 1990·Methods in Enzymology·F A Marston, D L Hartley
Jan 1, 1990·Methods in Enzymology·M Uhlén, T Moks
Jan 1, 1990·Methods in Enzymology·R J Kaufman
Jan 1, 1987·Methods in Enzymology·J P AbitaF Rey
Jan 1, 1987·Methods in Enzymology·R Shiman
Oct 15, 1995·The Biochemical Journal·S E HuftonR G Cotton
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·D KowlessurS Kaufman
Jan 1, 1993·Advances in Experimental Medicine and Biology·R G CottonI G Jennings
Jan 1, 1993·Advances in Experimental Medicine and Biology·M KnappskogJ Apold
Jan 1, 1996·Journal of Inherited Metabolic Disease·E TreacyR G Cotton
Jan 1, 1997·Nucleic Acids Research·P NowackiC R Scriver

❮ Previous
Next ❯

Citations

Sep 5, 2002·Journal of Neuroscience Research·Francisco Martinez-CruzJuan M Guerrero
Aug 1, 2008·Journal of Inherited Metabolic Disease·C N SarkissianC R Scriver
Jul 3, 1999·Trends in Genetics : TIG·C R Scriver, P J Waters
Mar 22, 2013·Journal of Human Genetics·María A BuenoMaría L Couce
Dec 27, 2002·The New England Journal of Medicine·Ania C MuntauAdelbert A Roscher
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·C N SarkissianC R Scriver
Sep 25, 1999·Genetic Testing·C ZekanowskiJ Bal
Nov 24, 2011·Genetic Testing and Molecular Biomarkers·Imen Ben-RebehBassam R Ali
Sep 26, 2000·Human Molecular Genetics·J M RodríguezM A Peñalva
May 11, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·John J MitchellCharles R Scriver
Jun 24, 1998·The Journal of Clinical Investigation·C R Scriver
Jan 19, 2010·Genetics and Molecular Research : GMR·L L SantosM R S Carvalho
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·S Kaufman
Mar 15, 2005·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Jane DelaneyCatherine J Waterfield
Jun 19, 2014·European Journal of Human Genetics : EJHG·Sarah WettsteinNenad Blau
Apr 29, 2016·Journal of Human Genetics·Luis Aldámiz-EchevarríaMaría L Couce
Jun 3, 2014·Expert Review of Molecular Diagnostics·Nenad BlauCarla Carducci
Sep 5, 2002·American Journal of Medical Genetics·Helen M Chao, Mary Ann Richardson
Sep 8, 1999·Human Mutation·P BrossN Gregersen
Dec 29, 1999·Human Mutation·C R ScriverP M Nowacki
Sep 6, 2008·Journal of Clinical Monitoring and Computing·Shaomin Yan, Guang Wu
Mar 26, 2003·Human Mutation·Charles R ScriverChristineh Sarkissian
Nov 28, 2017·Journal of Pediatric Endocrinology & Metabolism : JPEM·Lin WangRong Qiang
Jul 13, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sven F GarbadeNenad Blau
Feb 27, 2016·Human Mutation·Nenad Blau
Jul 17, 1999·Journal of Inherited Metabolic Disease·C R Scriver, P M Nowacki
Aug 18, 2000·Journal of Inherited Metabolic Disease·N GregersenB S Andresen
Jul 20, 2020·Toxicology and Applied Pharmacology·Rianita van OnselenTim G Downing
Apr 18, 2000·Molecular Genetics and Metabolism·I RiveraU Lichter-Konecki
Apr 18, 2000·Molecular Genetics and Metabolism·P LeandroD Konecki
Aug 13, 1999·Molecular Genetics and Metabolism·U Lichter-KoneckiD S Konecki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.